Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RIB and RISS block for analgesia in gynecomastia surgery
NCT04859803Phase 1Completed
- Sponsor
- Cairo University
- Start
- Jun 2021
- Primary completion
- Sep 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised trial of bupivacaine hydrochloride 0.75% injection in postoperative pain, sponsored by Cairo University. Primary endpoint: Morphine Consumption at 24 hours. Started Jun 2021; status: completed.
02
Drugs
bupivacaine hydrochloride 0.75% injection
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT04859803.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04859803.